akhatri

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 July 2025. Generic drug name (dm+d descriptor) Brand and/or Manufacturer Pack size Special container Betaxolol 0.25% eye drops 0.25ml unit dose preservative free Betoptic® 0.25% eye drops [...]

The post 3 products re-classified as special containers from July 2025 appeared first on Community Pharmacy England.

From July 2025, Category A reimbursement prices will be based on data from suppliers obtained under the Health Service Products (Provision and Disclosure of Information) Regulations 2018. This follows a transition period which took place over six financial quarters from April 2024 to the end of June 2025, with reimbursement prices determined using a variable [...]

The post Category A price-setting arrangements from July 2025 appeared first on Community Pharmacy England.

National Patient Safety Alert: Potential contamination of non-sterile alcohol-free skin cleansing wipes with Burkholderia spp: measures to reduce patient risk National Patient Safety Alert Reference Number:  NatPSA/2025/002/UKHSA Date of issue: 26/06/2025 Explanation of identified safety issue UKHSA is investigating an outbreak of Burkholderia stabilis involving individuals across the UK, linked to wipes. Following testing, Burkholderia [...]

The post National Patient Safety Alert: Potential contamination of non-sterile alcohol-free skin cleansing wipes with Burkholderia spp: measures to reduce patient risk appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Notification: Depo-Medrone 80 mg in 2 mL (Maxearn Limited) Drug alert number: EL(25)A/29 Date issued: 25 June 2025 A batch of Depo-Medrone has been released to the market with an error. The vial over label incorrectly states that the total vial content is 40 mg in 1 mL, when the correct [...]

The post MHRA Class 2 Medicines Recall: Depo-Medrone 80 mg in 2 mL (Maxearn Limited) appeared first on Community Pharmacy England.

UPDATE  (15/04/2026) to communication (MSN/2025/036U) issued on 14 August 2025. Levemir® products are being discontinued. Stock exhaustion is expected in December 2026. This notification is being re-issued, as a high number of patients remain on Levemir® products. Healthcare professionals are reminded to switch patients on Levemir® to a suitable alternative as soon as possible. Patients [...]

The post Updated Medicine Supply Notification: Levemir® (insulin detemir) FlexPen® 100units/ml solution for injection 3ml pre-filled pens and Levemir® Penfill 100units/ml solution for injection 3ml cartridges appeared first on Community Pharmacy England.